NEW YORK (360Dx) – Oxford Immunotec and Qiagen said today that they have settled a lawsuit alleging patent infringement of Oxford's patents by Qiagen's QuantiFERON-TB Gold and QuantiFERON-TB Gold Plus blood tests for tuberculosis infection.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.